Thomas E. Valentyn - Apr 12, 2024 Form 4 Insider Report for REGAL REXNORD CORP (RRX)

Signature
/s/ Thomas E. Valentyn
Stock symbol
RRX
Transactions as of
Apr 12, 2024
Transactions value $
$558
Form type
4
Date filed
4/16/2024, 04:54 PM
Previous filing
Feb 29, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % Price $ Shares After Date Ownership Footnotes
transaction RRX Common Stock Award $558 +3.42 +0.01% $163.09 28.4K Apr 12, 2024 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding RRX Stock Appreciation Rights 2.05K Apr 12, 2024 Common Stock 2.05K $78.05 Direct F2
holding RRX Stock Appreciation Rights 4.44K Apr 12, 2024 Common Stock 4.44K $151.27 Direct F3
holding RRX Stock Appreciation Rights 5.02K Apr 12, 2024 Common Stock 5.02K $154.20 Direct F3

Explanation of Responses:

Id Content
F1 Represents additional restricted stock units credited to the reporting person under the dividend equivalent reinvestment provision of the reporting person's outstanding restricted stock unit awards as a result of a quarterly dividend payment. The additional restricted stock units resulting from the dividend equivalent reinvestment are subject to the same terms and conditions, including vesting, as the outstanding restricted stock unit awards to which they are attributable.
F2 Granted as stock-settled Stock Appreciation Rights ("SARs") under the 2018 Equity Incentive Plan. The SARs vest and become exercisable 40% on the second anniversary, 60% on the third anniversary, 80% on the fourth anniversary and 100% on the fifth anniversary of the date of the grant.
F3 Granted as stock-settled SARs under the 2018 Equity Incentive Plan. The SARs vest and become exercisable 34% on the first anniversary, 67% on the second anniversary and 100% on the third anniversary of the date of the grant.

Remarks:

*Executive Vice President and Secretary